Bali, Vishal
Turzhitsky, Vladimir
Schelfhout, Jonathan
Paudel, Misti
Hulbert, Erin
Peterson-Brandt, Jesse
Hertzberg, Jeffrey
Kelly, Neal R.
Patel, Raja H.
Article History
Received: 2 February 2023
Accepted: 6 January 2024
First Online: 30 January 2024
Competing interests
: Vishal Bali and Vladimir Turzhitsky are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and have stock ownership of Merck & Co., Inc., Rahway, NJ, USA. At the time of the study, Jonathan Schelfhout was an employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and had stock ownership of Merck & Co., Inc., Rahway, NJ, USA. At the time of the study, Misti Paudel was an employee of Optum which was contracted by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA to complete this work. Erin Hulbert is an employee of Optum which was contracted by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA to complete this work. Jeffrey Hertzberg is an employee and stockholder of UnitedHealth Group/Optum. Jesse Peterson-Brandt, Neal R. Kelly, and Raja H. Patel have no conflicts of interest to report.